Conditional early approval for new drug applications in Japan: Current and emerging issues

por Tanaka, Mototsugu, Miyazawa, Haruna, Terashima, Ryohei, Ikuma, Mutsuhiro
Publicado 2023

Assessment of the impact of Japanese‐specific long‐term safety data on new drug approval

por Uzu, Shinobu, Sekine, Shohko, Asano, Junichi, Ikuma, Mutsuhiro
Publicado 2021

Exposure of Drugs for Hypertension, Diabetes, and Autoimmune Disease During Pregnancy and Perinatal Outcomes: An Investigation of the Regulator in Japan

por Sato, Ryosuke, Ikuma, Mutsuhiro, Takagi, Kazunori, Yamagishi, Yoshiaki, Asano, Junichi, Matsunaga, Yusuke, Watanabe, Hiroshi
Publicado 2015

Treatment with Corticosteroid for Pericardial Effusion in a Patient with Advanced Synchronous Esophageal and Gastric Cancers following Chemoradiotherapy

por Osawa, Satoshi, Yamada, Takanori, Saitoh, Takeji, Kosugi, Takashi, Terai, Tomohiro, Takayanagi, Yasuhiro, Hamaya, Yasushi, Sugimoto, Ken, Ikuma, Mutsuhiro
Publicado 2010

Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory Analysis

por Tanaka, Mototsugu, Idei, Mayumi, Sakaguchi, Hiroshi, Kato, Ryosuke, Sato, Daisuke, Sawanobori, Kenji, Kawarasaki, Shuichi, Hata, Toshiyuki, Yoshizaki, Asako, Nakamura, Miki, Ikuma, Mutsuhiro
Publicado 2020

Prospective study of daily low-dose nedaplatin and continuous 5-fluorouracil infusion combined with radiation for the treatment of esophageal squamous cell carcinoma

por Osawa, Satoshi, Furuta, Takahisa, Sugimoto, Ken, Kosugi, Takashi, Terai, Tomohiro, Yamade, Mihoko, Takayanagi, Yasuhiro, Nishino, Masafumi, Hamaya, Yasushi, Kodaira, Chise, Yamada, Takanori, Iwaizumi, Moriya, Takagaki, Kosuke, Yoshida, Ken-ichi, Kanaoka, Shigeru, Ikuma, Mutsuhiro
Publicado 2009